Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumors.

Chemotherapy

Volumn 48, Issue 4, 2002, Pages 205-210

  Nakanishi, Yoichi ^a   Takayama, Koichi ^a   Wataya, Hiroshi ^a   Izumi, Miiru ^a   Minami, Takahiro ^a   Takano, Koichi ^a   Inoue, Koji ^a   Osaki, Shin'ichi ^a   Kimotsuki, Kanehito ^a   Harada, Taishi ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DRUG DERIVATIVE; IRINOTECAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 18744401392     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063866     Document Type: Article

References (0)